Home › Triple-Negative Breast Cancer › New Jersey › Trenton
Triple-Negative Breast Cancer clinical trials in Trenton, NJ
3 studies for Triple-Negative Breast Cancer are looking for participants at sites in and around Trenton (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
RecruitingPhase 3
- Hunterdon Medical Center, Flemington · 21 mi away
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
RecruitingPhase 1/2
- USOR Alliance Cancer Specialist, Doylestown · 21 mi away
Phase 1 Study of CLR 125 in Triple Negative Breast Cancer
RecruitingPhase 1
- United Theranostics, Princeton · 10 mi away
Triple-Negative Breast Cancer trials in other cities
- Houston, TX42 studies
- New York City, NY31 studies
- Nashville, TN28 studies
- Los Angeles, CA27 studies
- Boston, MA26 studies
- San Antonio, TX23 studies
- St. Louis, MO21 studies
- Arlington, VA20 studies
- Atlanta, GA20 studies
- Dallas, TX18 studies
- Chicago, IL16 studies
- Columbus, OH16 studies
Other studies in Trenton
- Breast Cancer10 studies
- Psoriasis7 studies
- Type 2 Diabetes7 studies
- Heart Failure7 studies
- Cardiovascular Disease7 studies
- Obesity6 studies
- Depression4 studies
- Overweight4 studies
- Colorectal Cancer4 studies
- Ovarian Cancer4 studies
- High Blood Pressure4 studies
- Metastatic Cancer3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.